Skip to main content
logo
Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,840.00
-160.00 (-1.60%)
Aug 21, 2026, 3:30 PM KST

Whan In Pharm Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
20,45213,59523,38129,77423,92126,660
Depreciation & Amortization
9,8459,8658,4756,6594,8474,202
Loss (Gain) From Sale of Assets
267.38281.59330.111,1601,8976.22
Loss (Gain) From Sale of Investments
---392.98-1,168849.94-352.07
Loss (Gain) on Equity Investments
-941.1199.72-1,9811,006201.0861.86
Provision & Write-off of Bad Debts
1,2431,6931,396874.841,0661,094
Other Operating Activities
-2,283631.785,667714.37-3,124-229.16
Change in Accounts Receivable
-1,0067,4501,088-7,320-10,221-56.46
Change in Inventory
-12,530-24,239-22,546-17,631-3,89311.94
Change in Accounts Payable
3,324458.444,8669,2552,4093,555
Change in Other Net Operating Assets
-705.39-892.06411.23-128.37-1,102365.9
Operating Cash Flow
17,6669,04420,69323,19716,85135,318
Operating Cash Flow Growth
19.84%-56.30%-10.79%37.66%-52.29%55.21%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,604-2,850-27,357-30,531-33,650-4,387
Sale of Property, Plant & Equipment
0.550.553.9588.7480.4434.75
Sale (Purchase) of Intangibles
-151.83-3,332-2,024-941.14-642.7-374.92
Sale (Purchase) of Real Estate
---153.69-33,466-
Investment in Securities
-2,44710,98611,32121,77529,4892,409
Other Investing Activities
16.49-80.51-5858.41-779.69222.53
Investing Cash Flow
-5,1634,747-18,095-9,432-38,942-2,122

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--539.92-465.53-414.47-549.98-613.78
Net Debt Issued (Repaid)
-538.16-539.92-465.53-414.47-549.98-613.78
Issuance of Common Stock
11,39611,396----
Dividends Paid
-5,545-4,580-4,580-4,580-4,580-4,580
Other Financing Activities
-128.44307.91-4.95-171.43--
Financing Cash Flow
5,1846,584-5,051-5,166-5,130-5,194

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
85.858.17233.66-8.58-59.27-19.77
Net Cash Flow
17,77320,433-2,2198,591-27,28027,982

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
15,0626,194-6,664-7,334-16,79930,931
Free Cash Flow Growth
79.42%----109.47%
Free Cash Flow Margin
5.51%2.43%-2.57%-3.18%-8.44%17.40%
Free Cash Flow Per Share
862.30390.61-436.48-480.39-1100.322025.98
Levered Free Cash Flow
21,3949,973-20,163-21,346-23,44624,210
Unlevered Free Cash Flow
21,4159,991-20,148-21,332-23,41424,242

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
34.5528.7723.1222.6651.8851.55
Cash Income Tax Paid
8,9005,1795,0945,0098,3548,107
Change in Working Capital
-10,918-17,223-16,181-15,824-12,8073,876